Status:
COMPLETED
Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention
Lead Sponsor:
Inje University
Collaborating Sponsors:
Seoul National University Hospital
Keimyung University Dongsan Medical Center
Conditions:
Coronary Disease
Eligibility:
All Genders
20-85 years
Brief Summary
Fractional flow reserve (FFR) is a physiologic index for the determination of ischemia-causing coronary stenosis as well as drug eluting stent (DES) optimization, even multiple anatomic imaging parame...
Detailed Description
Patients who diagnosed obstructive coronary artery disease and treated by DES with FFR examination would be enrolled, consecutively. FFR measurement would be required at the baseline and at the end of...
Eligibility Criteria
Inclusion
- any patient meets eligible criteria who underwent PCI with DES followed by FFR measurement at the index procedure
- patient who provide informed consent
Exclusion
- culprit vessel of acute coronary syndrome
- failed achieving TIMI 3 flow at the end of PCI
- left ventricular ejection fraction \<30%
- graft vessel
- collateral feeder
- in-stent stenosis
- primary myocardial or valvular heart disease
- in patient whose life expectancy less than 2 years
- visible thrombus of target vessel segment
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT01873560
Start Date
May 1 2013
End Date
December 1 2016
Last Update
September 28 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University Ilsan Paik Hospital
Goyang-si, Gyeonggi-do, South Korea, 411-706
2
Keimyung University Dongsan Medical Center
Daegu, South Korea
3
Seoul National University Hospital
Seoul, South Korea
4
Ulsan University Hospital
Ulsan, South Korea